Dietary supplements are a $380 billion industry worldwide, but it’s hard to know which ones we truly need, especially during ...

evaluate the efficacy and safety of HTD1801 in T2DM patients (as monotherapy or in combination with metformin). We look forward to the results of these Phase 3 studies which we expect to announce in ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts. Export articles to Mendeley Get article recommendations from ACS based on references in your ...

The presentations include post-hoc analyses of two Phase 2 clinical studies of berberine ursodeoxycholate ... (as monotherapy or in combination with metformin). We look forward to the results ...

HONG KONG, Sept 11, 2024 - () - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for ...

Metformin significantly improved symptoms and resulted in hair regrowth in Black women with treatment-refractory central centrifugal cicatricial alopecia (CCCA), in a retrospective case series ...

Researchers from Michigan State University and South Shore Hospital have uncovered that the combination of two common diabetes drugs—injectable insulin and orally-administered metformin ...

Metformin may decrease the need for oral and intravenous steroids among individuals with concurrent type 2 diabetes and IBD. Metformin treatment reduces the odds of worse inflammatory bowel disease ...